Biosimilars & Innovator Biologics 2026
Organized by C5 Communications (C5 Group)
The 17th Summit on Biosimilars & Innovator Biologics focuses on Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilar Market Place.
- Dates
- Jun 2-3, 2026
- Location
- New York, NY
- Deadline
- -
- Attendees
- 500
- Vendors
- Unlock to view
About this conference
The 17th Summit on Biosimilars & Innovator Biologics focuses on Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilar Market Place. Attendees will connect with industry leaders to gain practical insights on evolving IP and litigation strategies, FDA and regulatory developments, market access and pricing pressures, and global competition shaping the future of biologics. This event aims to define the next phase of innovation and patient access within the biosimilars and innovator biologics community.
Sponsorship options
Sponsorship packages are tailored to meet individual organization’s needs, with a focus on identifying short and long-term objectives to develop a package for strong impact. Options can include logo placement (print and online), a sponsorship/exhibitor booth onsite, sponsorship of specific conference features (e.g., lanyards, lunches, cocktails), event passes, and a wider array of custom options.
Attendee roles and functions
Roles and teams represented at Biosimilars & Innovator Biologics
Find contacts by role
Conference verticals
Public-sector and commercial markets covered by this event
Vendors at this conference
Unlock full vendor list
See sponsors, exhibitors, and vendors attending this conference.